NO20005141L - Streptokokkpreparat - Google Patents
StreptokokkpreparatInfo
- Publication number
- NO20005141L NO20005141L NO20005141A NO20005141A NO20005141L NO 20005141 L NO20005141 L NO 20005141L NO 20005141 A NO20005141 A NO 20005141A NO 20005141 A NO20005141 A NO 20005141A NO 20005141 L NO20005141 L NO 20005141L
- Authority
- NO
- Norway
- Prior art keywords
- accession number
- streptococcus
- under accession
- number ncimb
- inflammation
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 241000194025 Streptococcus oralis Species 0.000 abstract 2
- 241000194023 Streptococcus sanguinis Species 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 241000606768 Haemophilus influenzae Species 0.000 abstract 1
- 241000588621 Moraxella Species 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 241001134658 Streptococcus mitis Species 0.000 abstract 1
- 241000193998 Streptococcus pneumoniae Species 0.000 abstract 1
- 210000000959 ear middle Anatomy 0.000 abstract 1
- 229940047650 haemophilus influenzae Drugs 0.000 abstract 1
- 208000022760 infectious otitis media Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801337A SE511648C2 (sv) | 1998-04-17 | 1998-04-17 | Streptokockpreparat för behandling av öroninflammation |
| PCT/SE1999/000608 WO1999053932A1 (en) | 1998-04-17 | 1999-04-16 | Streptococcus preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005141D0 NO20005141D0 (no) | 2000-10-13 |
| NO20005141L true NO20005141L (no) | 2000-12-14 |
Family
ID=20410988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005141A NO20005141L (no) | 1998-04-17 | 2000-10-13 | Streptokokkpreparat |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1071437A1 (is) |
| JP (1) | JP2002512196A (is) |
| AU (1) | AU4177799A (is) |
| CA (1) | CA2325805A1 (is) |
| ID (1) | ID26655A (is) |
| IL (1) | IL138958A0 (is) |
| IS (1) | IS5661A (is) |
| NO (1) | NO20005141L (is) |
| PL (1) | PL343547A1 (is) |
| SE (1) | SE511648C2 (is) |
| WO (1) | WO1999053932A1 (is) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060258596A1 (en) * | 2003-02-14 | 2006-11-16 | Walsh Timothy R | Antimicrobial agents |
| PL2349295T3 (pl) | 2008-11-17 | 2017-06-30 | Winclove Holding B.V. | Preparat farmaceutyczny zawierający kombinację szczepów paciorkowców i szczepów lactobacillus |
| FR2999601B1 (fr) | 2012-12-17 | 2015-01-30 | Urgo Lab | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
| PL3015109T3 (pl) * | 2014-10-28 | 2020-04-30 | D.M.G. Italia Srl | Bariera biologiczna z simetikonem do zastosowania w leczeniu zakażeń nosowo-gardłowo-przewodowych |
| CN119464165B (zh) * | 2025-01-16 | 2026-02-24 | 中日友好医院(中日友好临床医学研究所) | 口腔链球菌zrsor-5及其相关产品、方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH633188A5 (fr) * | 1978-05-26 | 1982-11-30 | Om Laboratoires Sa | Medicament contre des maladies infectieuses des voies respiratoires. |
| SE463349B (sv) * | 1989-02-15 | 1990-11-12 | Grahn Eva E | Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit |
-
1998
- 1998-04-17 SE SE9801337A patent/SE511648C2/sv not_active IP Right Cessation
-
1999
- 1999-04-16 IL IL13895899A patent/IL138958A0/xx unknown
- 1999-04-16 AU AU41777/99A patent/AU4177799A/en not_active Abandoned
- 1999-04-16 PL PL99343547A patent/PL343547A1/xx unknown
- 1999-04-16 EP EP99925517A patent/EP1071437A1/en not_active Withdrawn
- 1999-04-16 ID IDW20002358A patent/ID26655A/id unknown
- 1999-04-16 CA CA002325805A patent/CA2325805A1/en not_active Abandoned
- 1999-04-16 JP JP2000544336A patent/JP2002512196A/ja active Pending
- 1999-04-16 WO PCT/SE1999/000608 patent/WO1999053932A1/en not_active Ceased
-
2000
- 2000-10-13 IS IS5661A patent/IS5661A/is unknown
- 2000-10-13 NO NO20005141A patent/NO20005141L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9801337L (sv) | 1999-10-18 |
| CA2325805A1 (en) | 1999-10-28 |
| AU4177799A (en) | 1999-11-08 |
| JP2002512196A (ja) | 2002-04-23 |
| ID26655A (id) | 2001-01-25 |
| EP1071437A1 (en) | 2001-01-31 |
| IL138958A0 (en) | 2001-11-25 |
| NO20005141D0 (no) | 2000-10-13 |
| PL343547A1 (en) | 2001-08-27 |
| SE511648C2 (sv) | 1999-11-01 |
| WO1999053932A1 (en) | 1999-10-28 |
| IS5661A (is) | 2000-10-13 |
| SE9801337D0 (sv) | 1998-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lavollay et al. | The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L, D-transpeptidases | |
| Friedrich et al. | Molecular analyses of the natural transformation machinery and identification of pilus structures in the extremely thermophilic bacterium Thermus thermophilus strain HB27 | |
| Coffey et al. | Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae | |
| Novak et al. | Penicillin tolerance genes of Streptococcus pneumoniae: the ABC‐type manganese permease complex Psa | |
| Ogawa et al. | Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA | |
| Al‐Ghazzewi et al. | Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro | |
| BG102612A (en) | Complementary adenoviral vector systems and cellular lines | |
| Davies et al. | Evolutionary genetics of Pasteurella haemolytica isolates recovered from cattle and sheep | |
| MXPA04000808A (es) | Cepas probioticas de lactobacillus salivarius. | |
| SE9401806D0 (sv) | Method and means for the production of hyaluronic acid | |
| Albertí et al. | Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus | |
| WO2001025254A3 (en) | Novel adjuvant comprising a lipopolysaccharide antagonist | |
| MA20545A1 (fr) | Procede de preparation de souches de bacille thuringiensis presentant une activite amelioree a l'encontre de certains ravageurs du type l'epidoptere et nouvelle bouche ainsi preparee | |
| AU4660893A (en) | Deletion mutants as vaccines for cholera | |
| Fujita et al. | Biological functions of glucan‐binding protein B of Streptococcus mutans | |
| HK1046929A1 (zh) | 预防病原性细菌引起的腹泻的双歧杆菌 | |
| NO20005141L (no) | Streptokokkpreparat | |
| Fujiwara et al. | Biochemical and genetic characterization of serologically untypable Streptococcus mutans strains isolated from patients with bacteremia | |
| Bongaerts et al. | Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae | |
| Takada et al. | Streptococcus orisasini sp. nov. and Streptococcus dentasini sp. nov., isolated from the oral cavity of donkeys | |
| Deng et al. | Effects of the oral spirochete Treponema denticola on interleukin‐8 expression from epithelial cells | |
| Igarashi et al. | Inactivation of srtA gene of Streptococcus mutans inhibits dextran‐dependent aggregation by glucan‐binding protein C | |
| Sato et al. | gbpC and pac gene mutations detected in Streptococcus mutans strain GS‐5 | |
| WO2002064816A3 (en) | Multiple determinants for metabolic phenotypes | |
| Haenni et al. | Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |